NCT02584933 2026-02-03
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
Clinical Trials
5 trialsNCT05342883 2025-09-05
GESTALT
GT Medical Technologies, Inc.
Phase 4 Active not recruiting
NCT03849131 2025-03-12
PRAISE
University Hospital, Strasbourg, France
Phase 4 Active not recruiting
NCT06145321 2024-09-19
Continuous Versus Bolus Administration of G-CSF in Children With Cancer
Chang Gung Memorial Hospital
Phase 4 Active not recruiting
NCT02068196 2023-03-24
Ipi4
Oslo University Hospital
Phase 4 Active not recruiting